Humacyte (HUMA) Income Statement: Revenue & Earnings

Humacyte Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Humacyte, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	1.57	1.26	1.49
Cost of Revenue	88.60	76.55	63.26	61.34	54.08
Gross Profit	-88.60	-76.55	1.57	1.26	-52.59
Operating Expenses
Research & Development	88.60	76.55	63.26	61.34	0.00
Selling, General & Administrative	25.80	23.50	22.88	21.13	12.01
Operating Expenses	25.80	96.94	84.58	82.47	12.01
Operating Income	-114.40	-100.00	-84.58	-81.20	-64.60
Other Income/Expense
Interest Income	4.10	5.47	2.63	0.02	0.28
Interest Expense	-9.28	6.60	6.20	-4.35	-2.20
Other Income/Expense	3.92	-12.70	76.18	-60.33	0.00
Income
Income Before Tax	-148.70	-110.78	-11.97	-26.48	-66.52
Income Tax Expense	0.00	-2.07	-1.77	-1.71	0.00
Net Income	-148.70	-110.78	-11.97	-26.48	-66.52
Net Income - Continuous Operations	-148.70	-110.78	-11.97	-26.48	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-107.21	-96.46	2.45	-13.89	-56.25
EBIT	-114.40	-104.18	-5.77	-22.13	-64.60
Depreciation & Amortization	7.19	5.66	8.21	6.18	8.35
Earnings Per Share
Basic EPS	-1.00	-1.00	-	-1.00	-12.00
Diluted EPS	-1.00	-1.00	-	-1.00	-12.00
Basic Shares Outstanding	118.48	103.42	103.05	39.97	5.77
Diluted Shares Outstanding	118.48	103.42	103.05	39.97	5.77